» Articles » PMID: 20006679

The NG2 Proteoglycan Promotes Oligodendrocyte Progenitor Proliferation and Developmental Myelination

Overview
Journal Neuroscience
Specialty Neurology
Date 2009 Dec 17
PMID 20006679
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

The NG2 proteoglycan has been shown to promote proliferation and motility in a variety of cell types. The presence of NG2 on oligodendrocyte progenitor cells (OPCs) suggests that the proteoglycan may be a factor in expansion of the OPC pool to fill the entire CNS prior to OPC differentiation to form myelinating oligodendrocytes. Comparisons of postnatal cerebellar myelination in wild type and NG2 null mice reveal reduced numbers of OPCs in developing white matter of the NG2 null mouse. Quantification of BrdU incorporation shows that reduced proliferation is a key reason for this OPC shortage, with the peak of OPC proliferation delayed by 4-5 days in the absence of NG2. As a result of the subnormal pool of OPCs, there is also a delay in production of mature oligodendrocytes and myelinating processes in the NG2 null cerebellum. NG2 may promote OPC proliferation via enhancement of growth factor signaling or mediation of OPC interaction with unmyelinated axons.

Citing Articles

TET3-facilitated differentiation of human umbilical cord mesenchymal stem cells into oligodendrocyte precursor cells for spinal cord injury recovery.

Zhang Y, Peng Z, Guo M, Wang Y, Liu J, Liu Y J Transl Med. 2024; 22(1):1118.

PMID: 39707356 PMC: 11662714. DOI: 10.1186/s12967-024-05929-7.


Cspg4 sculpts oligodendrocyte precursor cell morphology.

Bromley-Coolidge S, Iruegas D, Appel B Differentiation. 2024; 140:100819.

PMID: 39566199 PMC: 11637897. DOI: 10.1016/j.diff.2024.100819.


Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma.

Chen X, Habib S, Alexandru M, Chauhan J, Evan T, Troka J Cancers (Basel). 2024; 16(19).

PMID: 39409881 PMC: 11476251. DOI: 10.3390/cancers16193260.


Lateral/caudal ganglionic eminence makes limited contribution to cortical oligodendrocytes.

Li J, Yang F, Tian Y, Wang Z, Qi D, Yang Z Elife. 2024; 13.

PMID: 39259197 PMC: 11390106. DOI: 10.7554/eLife.94317.


Nerve-Glial antigen 2: unmasking the enigmatic cellular identity in the central nervous system.

Bottero M, Pessina G, Bason C, Vigo T, Uccelli A, Ferrara G Front Immunol. 2024; 15:1393842.

PMID: 39136008 PMC: 11317297. DOI: 10.3389/fimmu.2024.1393842.


References
1.
Ligon K, Kesari S, Kitada M, Sun T, Arnett H, Alberta J . Development of NG2 neural progenitor cells requires Olig gene function. Proc Natl Acad Sci U S A. 2006; 103(20):7853-8. PMC: 1472534. DOI: 10.1073/pnas.0511001103. View

2.
Noll E, Miller R . Oligodendrocyte precursors originate at the ventral ventricular zone dorsal to the ventral midline region in the embryonic rat spinal cord. Development. 1993; 118(2):563-73. DOI: 10.1242/dev.118.2.563. View

3.
Raff M, Williams B, Miller R . The in vitro differentiation of a bipotential glial progenitor cell. EMBO J. 1984; 3(8):1857-64. PMC: 557609. DOI: 10.1002/j.1460-2075.1984.tb02059.x. View

4.
Horner P, Power A, Kempermann G, Kuhn H, Palmer T, Winkler J . Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci. 2000; 20(6):2218-28. PMC: 6772504. View

5.
Ong W, Levine J . A light and electron microscopic study of NG2 chondroitin sulfate proteoglycan-positive oligodendrocyte precursor cells in the normal and kainate-lesioned rat hippocampus. Neuroscience. 1999; 92(1):83-95. DOI: 10.1016/s0306-4522(98)00751-9. View